Compounds > cyc 202

Page last updated: 2024-09-04

cyc 202 and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

cyc 202 has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 7 studies

Compound Research Comparison

Studies (cyc 202)	Trials (cyc 202)	Recent Studies (post-2010) (cyc 202)	Studies (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)	Trials (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)	Recent Studies (post-2010) (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)
979	7	393	1,897	0	411

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	3 (42.86)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grubb, DR; Johnson, KL; Lawen, A	1
Bravo, R; Bruna, A; Caelles, C; Camarasa, J; Camins, A; Canudas, AM; Escubedo, E; Jiménez, A; Jorda, EG; Pallàs, M; Pubill, D; Verdaguer, E	1
Boix, J; Gomez-Arbones, X; Ribas, J	1
Brady, HJ; Caldicott, A; Crescenzi, E; Dransfield, I; Duffin, R; Gray, M; Haslett, C; Martin, MC; Martinez-Losa, M; Riley, NA; Rossi, AG; Savill, JS; Sawatzky, DA; Sheldrake, TA; Walker, A; Walker, TR; Ward, C	1
Camins, A; Canudas, AM; Crespo-Biel, N; Gutiérrez-Cuesta, J; Melchiorri, D; Nicoletti, F; Pallàs, M	1
Auladell, C; Beas-Zarate, C; Camins, A; Folch, J; Junyent, F; Pallàs, M; Pizarro, JG; Verdaguer, E	1
Blok, DC; Duitman, J; Hoogendijk, AJ; Roelofs, JJ; van der Poll, T; van Lieshout, MH; Wieland, CW	1

Other Studies

7 other study(ies) available for cyc 202 and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

Article	Year
Unspecific activation of caspases during the induction of apoptosis by didemnin B in human cell lines. Journal of cellular biochemistry, 1999, Feb-01, Volume: 72, Issue:2 Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Caspase 1; Caspase 3; Caspases; Cell Line; Depsipeptides; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Immunoblotting; Oligopeptides; Peptides, Cyclic; Poly(ADP-ribose) Polymerases; Purines; Roscovitine; Time Factors	1999
Neuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis. Neuropharmacology, 2003, Volume: 45, Issue:5 Topics: Amino Acid Chloromethyl Ketones; Animals; Animals, Newborn; Anthracenes; Anti-Bacterial Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Bromodeoxyuridine; Carrier Proteins; Caspase 3; Caspases; CDC2-CDC28 Kinases; Cell Count; Cell Survival; Cells, Cultured; Cerebellum; Chromatin; Colchicine; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Cytochromes c; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Flavonoids; Flow Cytometry; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Kainic Acid; MAP Kinase Kinase 4; Microtubules; Minocycline; Mitogen-Activated Protein Kinase Kinases; Neurons; Neuroprotective Agents; Piperidines; Purines; Rats; Rats, Sprague-Dawley; Roscovitine; Time Factors; Tubulin	2003
Caspase 8/10 are not mediating apoptosis in neuroblastoma cells treated with CDK inhibitory drugs. European journal of pharmacology, 2005, Nov-07, Volume: 524, Issue:1-3 Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Caspase 10; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cyclin-Dependent Kinases; Enzyme Inhibitors; Humans; Jurkat Cells; Kinetin; Neuroblastoma; Purines; Roscovitine; Time Factors	2005
Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nature medicine, 2006, Volume: 12, Issue:9 Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Azepines; Carrageenan; Caspase 3; Cyclin-Dependent Kinases; Enzyme Inhibitors; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Inflammation; Male; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Neutrophils; Pleurisy; Proto-Oncogene Proteins c-bcl-2; Purines; Pyrroles; Roscovitine	2006
Regulation of GSK-3beta by calpain in the 3-nitropropionic acid model. Hippocampus, 2010, Volume: 20, Issue:8 Topics: Amino Acid Chloromethyl Ketones; Aminophenols; Animals; Calpain; Caspases; Cell Survival; Cells, Cultured; Convulsants; Disease Models, Animal; Embryo, Mammalian; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Male; Maleimides; Mice; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nitro Compounds; Propionates; Purines; Rats; Roscovitine; Signal Transduction; Time Factors	2010
Antiapoptotic effects of roscovitine on camptothecin-induced DNA damage in neuroblastoma cells. Apoptosis : an international journal on programmed cell death, 2011, Volume: 16, Issue:5 Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Calpain; Camptothecin; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Dipeptides; DNA Damage; DNA-Binding Proteins; Humans; Morpholines; Neuroblastoma; Protein Serine-Threonine Kinases; Purines; Pyrones; Roscovitine; Tumor Suppressor Proteins	2011
R-roscovitine reduces lung inflammation induced by lipoteichoic acid and Streptococcus pneumoniae. Molecular medicine (Cambridge, Mass.), 2012, Sep-25, Volume: 18 Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Caspase 3; Cell Line; Chemokines; Cyclin-Dependent Kinases; Female; Humans; Inflammation Mediators; Leukocyte Count; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Neutrophils; Pneumonia; Purines; Roscovitine; Streptococcus pneumoniae; Teichoic Acids	2012